Nebius Group (NBIS) shares surged to an all-time high of $279.80, up 6.1% in one day, driven by its $643 million acquisition of Eigen AI and confirmed entry into the Nasdaq-100 index. The acquisition enhances NBIS's AI infrastructure with advanced inference and optimization capabilities, while Nasdaq-100 inclusion is prompting passive funds to buy the stock. The company also expanded its UK AI infrastructure and energy partnerships. Despite insider selling, analysts maintain a "Moderate Buy" consensus with an average price target below current levels, reflecting optimism about NBIS's growth prospects.
Apollo Global Management reported record fee-related earnings of $785 million in Q2, a 25% increase year-over-year, with fee margins expanding to 58.5%. The company saw strong 34% growth in fee-generating assets under management and achieved a record...
In Austria, selling Bitcoin directly between private individuals is taxed the same as sales via crypto exchanges. The taxable event is the capital gain—the difference between sale proceeds and acquisition cost—with a 27.5% tax rate for Bitcoin acquir...
The U.S. SEC has approved Evernorth's registration, clearing the way for its $1 billion Nasdaq listing under the ticker XRPN through a merger with Armada Acquisition Corp. II. Evernorth plans to actively manage its XRP treasury to generate yield and ...
Amprius Technologies is benefiting from strong demand for drone batteries, reporting a 125.7% year-over-year revenue increase and improved gross margins. The company raised its 2026 revenue forecast to at least $140 million and aims for $600 million ...
INmune Bio is considered significantly undervalued with its treatment Ebstrocel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) driving a strong investment case. Ebstrocel offers systemic itch reduction, setting it apart from competitors like K...
